Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Pharmaceutical Retailers

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, comprising medicines, vitamins, medical devices, and test kits; and offers consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers. The company also provides wholesale cash and carry; diagnostic, pathological, and laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. It operates stores in Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, West Bengal, Maharashtra, Orissa, Madhya Pradesh, Chhattisgarh, Kerala, and Puducherry, as well as online platform. The company was incorporated in 2006 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for MEDPLUS
Revenue projections for MEDPLUS

The projected decline in MEDPLUS's revenues compared to last year is expected to make investors cautious. A drop in revenue often has a direct negative effect on the company's bottom line, signaling potential challenges that could undermine investor confidence and reduce overall profitability.

Financial Ratios:

currentRatio 2.90300
forwardPE 40.49126
debtToEquity 64.68900
earningsGrowth 0.43000
revenueGrowth 0.06500
grossMargins 0.25567
operatingMargins 0.04781
trailingEps 16.26000
forwardEps 15.12000

MedPlus Health Services Limited's current ratio is 2.903, signaling that the company has sufficient cash reserves and current assets to cover its short-term debt obligations. This suggests financial stability, as MedPlus Health Services Limited should not face any issues meeting its short-term liabilities with available resources.
MEDPLUS's lower forward EPS compared to trailing EPS suggests the company will likely experience reduced earnings in the current year. This may signal a less optimistic financial outlook.

Price projections:

Price projections for MEDPLUS
Price projections for MEDPLUS

The current valuation of MEDPLUS against its projections does not reveal significant risks or opportunities. This neutral assessment implies a stable market, where investors may prefer to maintain their positions until future trends become clearer.

Recommendation changes over time:

Recommendations trend for MEDPLUS
Recommendations trend for MEDPLUS


Analysts' recent buy bias toward MEDPLUS suggests the stock is gaining favor as a strong investment choice. This optimism could drive more investors to see MEDPLUS as a smart place to invest, further bolstering confidence in the company's long-term growth and potential returns.